These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 1379664

  • 21. Cisplatin and 5-fluorouracil in recurrent head and neck cancer: results of an outpatient schedule.
    Airoldi M, Pedani F, Brando V, Giordano C, Gabriele P.
    Chemioterapia; 1988 Apr; 7(2):127-9. PubMed ID: 3396116
    [Abstract] [Full Text] [Related]

  • 22. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM.
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [Abstract] [Full Text] [Related]

  • 23. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH.
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [Abstract] [Full Text] [Related]

  • 24. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
    Hussain M, Gadgeel S, Kucuk O, Du W, Salwen W, Ensley J.
    Cancer; 1999 Dec 01; 86(11):2364-9. PubMed ID: 10590379
    [Abstract] [Full Text] [Related]

  • 25. Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer.
    Kohno N, Ichikawa G, Shirasaka T, Inuyama Y, Kawaida M, Ohnuma T.
    Gan To Kagaku Ryoho; 1995 Aug 01; 22 Suppl 3():209-14. PubMed ID: 7661582
    [Abstract] [Full Text] [Related]

  • 26. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
    Chambers SK, Lamb L, Kohorn EI, Schwartz PE, Chambers JT.
    Gynecol Oncol; 1994 May 01; 53(2):161-9. PubMed ID: 7514557
    [Abstract] [Full Text] [Related]

  • 27. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.
    Argiris A, Li Y, Murphy BA, Langer CJ, Forastiere AA.
    J Clin Oncol; 2004 Jan 15; 22(2):262-8. PubMed ID: 14722034
    [Abstract] [Full Text] [Related]

  • 28. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group.
    Clavel M, Vermorken JB, Cognetti F, Cappelaere P, de Mulder PH, Schornagel JH, Tueni EA, Verweij J, Wildiers J, Clerico M.
    Ann Oncol; 1994 Jul 15; 5(6):521-6. PubMed ID: 7522527
    [Abstract] [Full Text] [Related]

  • 29. Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.
    Herbst RS, Arquette M, Shin DM, Dicke K, Vokes EE, Azarnia N, Hong WK, Kies MS.
    J Clin Oncol; 2005 Aug 20; 23(24):5578-87. PubMed ID: 16009949
    [Abstract] [Full Text] [Related]

  • 30. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F, Comella P, Marcolin P, Russo Spena F, Biglietto M, Cartenì G, De Lucia L, Avallone A, Gravina A, Comella G.
    Cancer; 1999 Feb 15; 85(4):952-9. PubMed ID: 10091775
    [Abstract] [Full Text] [Related]

  • 31. [Clinical effects and toxicity of chemotherapy with cisplatin for head and neck cancer--the multi-institutional joint research in Tokai district].
    Tohnai I, Kawabe Y, Nakashima T, Yamagiwa M, Suzuki T, Mizuno A, Mineda H.
    Nihon Gan Chiryo Gakkai Shi; 1990 Oct 20; 25(10):2567-78. PubMed ID: 1702133
    [Abstract] [Full Text] [Related]

  • 32. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gebbia V, Valenza R, Testa A, Borsellino N, Cannata G, Restivo S, Speciale R, Ingria F, Spadafora G, Gebbia N.
    ORL J Otorhinolaryngol Relat Spec; 1994 Oct 20; 56(5):279-82. PubMed ID: 7526312
    [Abstract] [Full Text] [Related]

  • 33. Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers.
    Woods RL, Stewart J, Fox RM, Tattersall MH.
    Cancer Treat Rep; 1979 Oct 20; 63(11-12):1997-9. PubMed ID: 93514
    [Abstract] [Full Text] [Related]

  • 34. [Role of neoadjuvant chemotherapy in the treatment of advanced head and neck tumors. Results of two randomized therapeutical trials conducted at the Institut Curie on 208 patients].
    Brunin F, Rodriguez J, Jaulerry C, Mosseri V, Jouve M, Point D, Asselain B, Validire P, Blaszka B, Zafrani B.
    Bull Cancer; 1992 Oct 20; 79(9):893-904. PubMed ID: 1283088
    [Abstract] [Full Text] [Related]

  • 35. Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma.
    Tellez-Bernal E, Belehradek M, Recondo G, Cvitkovic E, Leridant AM, Vericel R, Armand JP.
    Am J Clin Oncol; 1990 Oct 20; 13(5):452-4. PubMed ID: 1699403
    [Abstract] [Full Text] [Related]

  • 36. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA, Metch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P, Kish JA, McClure S, VonFeldt E, Williamson SK.
    J Clin Oncol; 1992 Aug 20; 10(8):1245-51. PubMed ID: 1634913
    [Abstract] [Full Text] [Related]

  • 37. Mitomycin C, cisplatin, and 5-fluorouracil for advanced and/or recurrent head and neck squamous cell carcinomas.
    Iop A, Cartei G, Vigevani E, Clocchiatti L, Mansutti M, Sibau AM.
    Am J Clin Oncol; 1997 Oct 20; 20(5):515-8. PubMed ID: 9345340
    [Abstract] [Full Text] [Related]

  • 38. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
    Clavel M, Cognetti F, Dodion P, Wildiers J, Rosso R, Rossi A, Gignoux B, Van Rymenant M, Cortes-Funes H, Dalesio O.
    Cancer; 1987 Sep 15; 60(6):1173-7. PubMed ID: 2441836
    [Abstract] [Full Text] [Related]

  • 39. [Factors modifying remission in cytostatic chemotherapy of squamous cell carcinoma recurrence in the area of the head and neck].
    Scherlacher A, Jakse R, Lehnert M, Haas J.
    Laryngorhinootologie; 1989 Aug 15; 68(8):425-32. PubMed ID: 2476996
    [Abstract] [Full Text] [Related]

  • 40. Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin.
    Dimery IW, Legha SS.
    J Clin Oncol; 1986 Nov 15; 4(11):1670-6. PubMed ID: 3095503
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.